Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Palmerini

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
ESMO Open|December 23, 2021
A special jubilee: 100 fake osteosarcoma articlesS S Bielack, E Palmerini
Bollettino Della Societa Italiana Di Cardiologia|January 1, 1973
[Contribution to the knowledge of Prinzmetal's variant of angina: clinical and instrumental study]D Di Gregorio, A Rossi, E Palmerini
Internal Medicine Journal|May 25, 2011
New onset of electrocardiographic abnormalities heralding hypertrophic cardiomyopathy in an adult athleteS Mondillo, I Olivotto, E Palmerini, et al.
The Journal of Bone and Joint Surgery. British Volume|August 1, 2006
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patientsG Bacci, N Fabbri, A Balladelli, et al.
La Radiologia Medica|August 9, 2012
Palliative embolisation for advanced bone sarcomasA F Mavrogenis, G Rossi, G Altimari, et al.
Journal of Chemotherapy (Florence, Italy)|May 9, 2009
Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcomaS Ferrari, E Palmerini, E Staals, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 4, 2012
Palliative treatments for advanced osteosarcomaA F Mavrogenis, G Rossi, E Palmerini, et al.
Pediatric Blood & Cancer|January 15, 2009
Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcomaS Ferrari, A Brach del Prever, E Palmerini, et al.
British Journal of Cancer|August 12, 2004
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade gliomaE Franceschi, G Cavallo, L Scopece, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2011
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group studyG Grignani, E Palmerini, P Dileo, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
ESMO Open|December 23, 2021
A special jubilee: 100 fake osteosarcoma articlesS S Bielack, E Palmerini
Bollettino Della Societa Italiana Di Cardiologia|January 1, 1973
[Contribution to the knowledge of Prinzmetal's variant of angina: clinical and instrumental study]D Di Gregorio, A Rossi, E Palmerini
Internal Medicine Journal|May 25, 2011
New onset of electrocardiographic abnormalities heralding hypertrophic cardiomyopathy in an adult athleteS Mondillo, I Olivotto, E Palmerini, et al.
The Journal of Bone and Joint Surgery. British Volume|August 1, 2006
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patientsG Bacci, N Fabbri, A Balladelli, et al.
La Radiologia Medica|August 9, 2012
Palliative embolisation for advanced bone sarcomasA F Mavrogenis, G Rossi, G Altimari, et al.
Journal of Chemotherapy (Florence, Italy)|May 9, 2009
Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcomaS Ferrari, E Palmerini, E Staals, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 4, 2012
Palliative treatments for advanced osteosarcomaA F Mavrogenis, G Rossi, E Palmerini, et al.
Pediatric Blood & Cancer|January 15, 2009
Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcomaS Ferrari, A Brach del Prever, E Palmerini, et al.
British Journal of Cancer|August 12, 2004
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade gliomaE Franceschi, G Cavallo, L Scopece, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2011
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group studyG Grignani, E Palmerini, P Dileo, et al.
Pageof 3